Logo
Subscribe Now

receives

Genentech's Susvimo Receives the US FDA's Approval for the Treatment of Wet Age-Related Macular Degeneration

Genentech's Susvimo Receives the US FDA's Approval for the Treatment of Wet Age-Related Macular Degeneration

Pfizer's Prevnar 20 (Pneumococcal 20-Valent Conjugate Vaccine) Receives the CDC's Advisory Committee Recommendation for Invasive Disease and Pneumonia

Pfizer's Prevnar 20 (Pneumococcal 20-Valent Conjugate Vaccine) Receives the CDC's Advisory Committee Recommendation for Invasive Disease and Pneumonia

Gilead's Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide) Low-Dose Tablet Receives the US FDA's Approval for Expanded Indication to Treat HIV-1

Gilead's Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide) Low-Dose Tablet Receives the US FDA's Approval for Expanded Indication to Treat HIV-1

Sanofi's Dupixent (dupilumab) Receives NICE Recommendation for the Treatment of Severe Asthma

Sanofi's Dupixent (dupilumab) Receives NICE Recommendation for the Treatment of Severe Asthma

Genentech's Tecentriq Receives the US FDA's Approval as Adjuvant Treatment for Early Non-Small Cell Lung Cancer

Genentech's Tecentriq Receives the US FDA's Approval as Adjuvant Treatment for Early Non-Small Cell Lung Cancer

AbbVie-Skyrizi (risankizumab) Receives CHMP's Positive Opinion for the Treatment of Adults with Active Psoriatic Arthritis in the EU

AbbVie-Skyrizi (risankizumab) Receives CHMP's Positive Opinion for the Treatment of Adults with Active Psoriatic Arthritis in the EU

Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2021 PharmaShots - All Rights Reserved.